C. Boutros
Institut Gustave Roussy · 68 works · 4,705 citations · h-index 15
Top works
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
- Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab
- Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma
- 1139P Long-term safety profile of pembrolizumab monotherapy and relationship with clinical outcome: A pooled analysis of patients with advanced melanoma
- Renal effects of immune checkpoint inhibitors
- Immune Checkpoint Inhibitor Therapy Aggravates T Cell–Driven Plaque Inflammation in Atherosclerosis
- Arterial thrombosis and anti-PD-1 blockade
- Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells
- Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma
- New Era in the Management of Melanoma Brain Metastases
- Outcomes of patients with cancer and sarcoid-like granulomatosis associated with immune checkpoint inhibitors: A case–control study
- Pulmonary nodules and immunotherapy: disease progression or toxicity of anti-PD1/anti-PDL1 checkpoint inhibitors?
- Denosumab related osteonecrosis of the jaw: Unusual pattern with periosteal reaction
- Severe ototoxicity associated with immune checkpoint inhibitors (ICI) in advanced melanoma
- Activity and safety of oral etoposide in pretreated patients with metastatic or recurrent thymic epithelial tumors (TET): A single-institution experience
- Antitumor activity in advanced cancer patients with thymic malignancies enrolled in early clinical drug development programs (Phase I trials) at Gustave Roussy
- Experience with palliative care in patients with advanced cancer at a tertiary care hospital in a developing country
- Dose escalation phase 1 study of radiotherapy in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 monoclonal antibody ipilimumab in patients with metastatic melanoma
- A preoperative nomogram to predict the risk of synchronous distant metastases at diagnosis of primary breast cancer